Infinity Pharma (INFI) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Infinity Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update
November 2, 2021 4:05 PM EDTEncouraging data for eganelisib in both PD-L1(-) and PD-L1(+) mTNBC patients, with meaningful prolongation of PFS over IMpassion130 reference benchmark
Updated mTNBC data to be presented at San Antonio Breast Cancer Symposium
Encouraging data for eganelisib in mUC patients, with a 7.5 month extension of overall survival versus control arm
Strengthened leadership team with Chief Scientific Officer, Chief Medical Officer and Board appointments
CAMBRIDGE, Mass.--(BUSINESS... More
